PBYI
PUMA BIOTECHNOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.54
−0.75%Forward multiples
Based on analyst estimates
- P/E forward
- 45.83x
- P/E 2026E
- 27.79x
- P/E 2027E
- 52.80x
- P/E 2028E
- 70.40x
- P/S forward
- 8.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.66x
- PEG TTM
- 0.09x
- Price / book
- 3.93x
- Price / sales
- 2.35x
- Price / cash flow
- 13.22x
Enterprise value
- Enterprise value
- $455.0M
- EV / sales
- 1.97x
- EV / EBITDA
- 10.07x
- EV / EBIT
- 14.95x
- Market cap
- $544.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026